Gul Ozcelik
Overview
Explore the profile of Gul Ozcelik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dincer B, Ozcelik G, Urganci N
Sisli Etfal Hastan Tıp Bul
. 2024 Oct;
58(3):359-362.
PMID: 39411037
Objectives: Familial Mediterranean fever (FMF) is an autoinflammatory disease more commonly observed in the Eastern Mediterranean region. Studies have shown that inflammatory processes may decrease vitamin D, vitamin B12 and...
2.
Leventoglu E, Ozdemir Atikel Y, Nalcacioglu H, Dursun I, Dursun H, Yildirim Z, et al.
Turk J Med Sci
. 2023 Mar;
52(6):1762-1770.
PMID: 36945974
Background/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials...
3.
Yuruk Yildirim Z, Usta Akgul S, Alpay H, Aksu B, Savran Oguz F, Kiyak A, et al.
Cell Stress Chaperones
. 2021 Oct;
26(6):973-987.
PMID: 34671941
Various molecular and cellular processes are involved in renal fibrosis, such as oxidative stress, inflammation, endothelial cell injury, and apoptosis. Heat shock proteins (HSPs) are implicated in the progression of...
4.
Balat A, Demircioglu Kilic B, Aksu B, Akbalik Kara M, Buyukcelik M, Agbas A, et al.
Pediatr Nephrol
. 2021 Jul;
37(2):393-402.
PMID: 34331573
Background: Children are one of the most vulnerable groups in conflict zones, especially those with chronic diseases. This study aimed to investigate kidney disease profiles and problems during follow-up in...
5.
Yildirmak Z, Ozcelik G, Ozagari A, Genc D, Onay H
J Pediatr Hematol Oncol
. 2021 Jul;
44(2):e431-e433.
PMID: 34224517
Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is a recently identified form of congenital neutropenia associated with developmental anomalies. The severity of neutropenia and the clinical spectrum are highly variable. Aside...
6.
Canpolat N, Yildirim Z, Yildiz N, Tasdemir M, Goknar N, Evrengul H, et al.
Eur J Pediatr
. 2021 Jul;
181(1):117-123.
PMID: 34218318
The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis...
7.
Tasdemir M, Canpolat N, Yildiz N, Ozcelik G, Benzer M, Saygili S, et al.
Turk J Med Sci
. 2021 Feb;
51(4):1781-1790.
PMID: 33581711
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome,
considering the type of disease (steroid-sensitive or –resistant) and the dosing regimen. Materials And...
8.
Dalkilinc A, Demirkan H, Ozcelik G
Sisli Etfal Hastan Tıp Bul
. 2021 Feb;
53(1):46-48.
PMID: 33536826
Objectives: Urinary tract stones are less common in children than in adults. Determining the etiology is the most important step to achieve successful treatment and prevent future recurrence. The aim...
9.
Pinarbasi A, Dursun I, Gokce I, Comak E, Saygili S, Torun Bayram M, et al.
Pediatr Nephrol
. 2020 Nov;
36(5):1195-1205.
PMID: 33130981
Background: C3 glomerulopathy (C3G) is characterized by heterogeneous clinical presentation, outcome, and predominant C3 accumulation in glomeruli without significant IgG. There is scarce outcome data regarding childhood C3G. We describe...
10.
Holle J, Kirchner M, Okun J, Bayazit A, Obrycki L, Canpolat N, et al.
PLoS One
. 2020 Oct;
15(10):e0240446.
PMID: 33108385
The uremic toxins indoxyl sulfate (IS) and p-cresyl sulfate (pCS) accumulate in patients with chronic kidney disease (CKD) as a consequence of altered gut microbiota metabolism and a decline in...